In this piece, we will look at the stocks that Jim Cramer recently discussed.
In one of his latest appearances on CNBC’s Squawk on the Street, Jim Cramer started the morning by commenting on the latest Producer Price Index (PPI) release. The PPI, which tracks inflation upstream of the supply chain, rose by 0.2% in December and fell short of economist expectations of 0.3%. However, this didn’t lead to any significant reaction in the bond market. According to Cramer, “Carl these, the bonds just don’t want to react to anything good. Of course, we can immediately say, it’s because we’re gonna get a tough CPI number tomorrow. The fact is, is these numbers are tame. People have to start recognizing that there are some good numbers coming.”
He shared other factors that might be fueling the bond market’s performance. “House prices coming down, food coming down, but it doesn’t seem to matter,” Cramer remarked. He added “What the bonds are reacting to I think is a new administration, uh, concern about what is going to be, uh, tariffs, even though it looks like they’re going to be phased in. You know David, interest rates don’t wanna come down here. And they don’t wanna come down there’s too much issuance, there’s a belief that the next administration is much more inflationary. And David it doesn’t seem to matter what is printed, the bonds don’t want to go higher. Interest rate’s not low enough.”
Another news that has made a lot of headlines recently is TikTok’s fate in the US. Cramer believes that rather than a complete bank, there could “be a gradual diminution of the service. In other words, it’s not going to be turned off. I think that this whole idea that the Chinese Communist Party is really just a gigantic private equity firm leaves me cold. I just don’t think that they are in a situation to broker a deal.”
One person that the CNBC TV show host believes isn’t discussed enough is electric vehicle billionaire Elon Musk. “I mean, Carl, it’s so exciting to talk about Elon Musk. I mean we haven’t talked about Elon, you know you have to wait maybe to nine o’ four to talk about Elon Musk. I just say we do it at the very top,” believes Cramer. He added “We have Elon Musk being the most important, well, he’s, he’s co-president right now which I think is a little absurd.. . . this man has become, Carl, a nation-state within. He’s a state within a state.”
On the topic of markets, Cramer was appreciative of the fact that the market and equal-weighted benchmark S&P indexes are up identically over the last six months “Well look I, that’s good news actually. We want to have broader leadership,” he remarked. However, without Wall Street’s favorite AI stock, Cramer believes “you have a market that’s kind of ruthless. . . David, you know that this market survives on NASDAQ fuel and not on Dow fuel. And yet people still insist on talking about the Dow.”
Finally, Cramer has also spent quite a bit of time discussing social media CEO Mark Zuckerberg’s appearance on the Joe Rogan Experience podcast. This time around, he shared “I’ll go right to Joe Rogan. I’ll be five hours in Joe Rogan. One of the most jarring things about the Joe Rogan interview was that he said he had to take a bathroom break. Well, there’s professionalism personified.” Cramer also commented on whether 38% is too much for an interviewer to speak. Taking a mixed view, he stated “I think it is. I used to put a stopwatch to my show Kudlow & Cramer. I got to speak 38% of the time so you know what, maybe it’s not so bad.”
Our Methodology
To make our list of the stocks that Jim Cramer talked about, we listed down all the stocks he mentioned during CNBC’s Squawk on the Street aired yesterday.
For these stocks, we also mentioned the number of hedge fund investors. Why are we interested in the stocks that hedge funds invest in? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).
13. KB Home (NYSE:KBH)
Number of Hedge Fund Holders In Q3 2024: 27
KB Home (NYSE:KBH) is a mid-sized American home-building company. Its shares posted a mere 5% in gains in 2024 as continued high interest rates and tight housing inventory meant that prices remained out of reach for a lot of buyers. KB Home (NYSE:KBH)’s shares are particularly sensitive to interest rates as was evident in December. After the Fed pared back its rate cut guidelines for 2025, the stock slipped by 4.5% to add to December’s mounting losses. However, KB Home (NYSE:KBH)’s shares are up by 3.9% year-to-date after it forecasted 2025 housing revenue to range between $7 billion and $7.5 billion for growth over last year’s $6.9 billion. Here is what Cramer said:
“We look at KB Homes, which is the first good report we’ve had when it comes to housing. And, look, labor’s still tight, people can’t find enough skilled workers. I mean the numbers were okay. I know that the margins were not what I wanted. Some of that is also because they have to do some price concessions, mortgage rates have moved up. Carl, I see a market, I don’t wanna say that nothing good can happen because KB Homes is just soaring on the idea that it wasn’t worst than expected. But we just have a cloud over everything and I just think that anytime you get too excited about stocks, yesterday we got excited about stocks and it was only the Dow stocks, it was not tech. I think if you find yourself saying well why did I bid things up? I’m not negative here. I’m positive here. I think that reflects, Carl, the mood of this market.”
12. Signet Jewelers Limited (NYSE:SIG)
Number of Hedge Fund Holders In Q3 2024: 34
Signet Jewelers Limited (NYSE:SIG) is a luxury goods company that focuses on diamond jewelry. Its shares lost 17% in 2024 as the firm struggled in a depressed consumer spending environment. 2024 was marred by Signet Jewelers Limited (NYSE:SIG) missing analyst expectations for several quarterly guidance figures, but at the same time, the low bar set by a weakening consumer also led to rare strong share price performance once the firm overcame it. Signet Jewelers Limited (NYSE:SIG)’s shares crashed by 20% in January after the firm’s $2.3275 billion in midpoint fiscal Q4 guidance was a drop from the earlier $2.42 billion. Here’s what Cramer said after the cut:
“Yeah, look, I don’t know, they lost [laughs] Gina Drosos. I think she was a remarkable CEO. And I think this is a very CEO-led company. This is not a given when it comes to jewelry.”
11. Cardinal Health, Inc. (NYSE:CAH)
Number of Hedge Fund Holders In Q3 2024: 40
Cardinal Health, Inc. (NYSE:CAH) is one of the biggest healthcare service providers in the US. The firm caters to the needs of the hospital, pharmacy, and other associated healthcare industries. Cardinal Health, Inc. (NYSE:CAH)’s shares gained 18% in 2024 as the firm managed to benefit from the high-margin nature of specialty medicines for diseases such as arthritis and cancer. The strong performance in these segments was followed and accompanied by Cardinal Health, Inc. (NYSE:CAH) acquiring gastroenterology and oncology companies to further grow its portfolio. Cramer believes that the market reaction to the stock is unwarranted:
“And Cardinal Health up, why? Very simply, because Cardinal Health is a middle man, people didn’t want to own it. Turned out to be better than expected.
“I would absolutely do the opposite of everything I just said in terms of where stocks are going. Everything. Take the other side of everyone of those trades. Take the other side.”
10. United Rentals, Inc. (NYSE:URI)
Number of Hedge Fund Holders In Q3 2024: 45
United Rentals, Inc. (NYSE:URI) is an industrial and construction rental equipment provider. As a result, its fate depends on the health of the interest rate-sensitive construction and industrial sectors. Yet, United Rentals, Inc. (NYSE:URI)’s shares were up by 25% in 2024 as it benefited from strong earnings that enabled it to grow revenue by 9% during the first three quarters of the year. Year-to-date, the stock is up by 5.8% as the firm aims to grow its equipment portfolio by acquiring H&E for $4.8 billion. Here’s what Cramer said about United Rentals, Inc. (NYSE:URI)’s latest move:
“If I were either Jonathan Kanter at the anti trust division of the Justice Department or I was Lina Khan who runs the FTC, I would veto this deal immediately. Why? Because they’re in the same industry. H&E this is a terrific product. It makes, it’s another rental. URI used to be a roll up, they kind of stopped that because they knew that everything would be blocked by antitrust. David, we’re back. You can merge anybody. Why not? You can just merge anybody. These are two companies that could compete, what the heck, why don’t you merge them and make it so everybody’s better for it. Particularly the shareholders.”
9. Honeywell International Inc. (NASDAQ:HON)
Number of Hedge Fund Holders In Q3 2024: 55
Honeywell International Inc. (NASDAQ:HON) is one of the biggest industrial conglomerates in America. It targets customers in the aerospace, defense, construction, energy, and other industries with its products. Honeywell International Inc. (NASDAQ:HON)’s shares gained 9.4% in 2024 as the firm was beset with a broader industrial slowdown and pressure from activist investors. Its industrial automation sales dropped by 5% during the fiscal third quarter due to supply chain disruptions. The broader slowdown has increased pressure on Honeywell International Inc. (NASDAQ:HON) to spin off its businesses and streamline operations. Here’s what Cramer said:
“Honeywell, doing what Elliot Partners wants. Which is to split automation and aero. People thought that this would be a great idea. Whatever Honeywell seems to do is disappointing. A lot of that is because of the earnings which have not been up to snuff. I think that this is an opportunity. The stock is down 5% for the year. Even though they’re doing something that could be very much like what GE did. When they split into energy, healthcare, and then core aerospace. I think the stock is a buy but people want to see the quarter which they think will be a disappointment. And they want to sell ahead of that. I say let them do it. The parts are worth more than the whole.”
8. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Number of Hedge Fund Holders In Q3 2024: 62
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a New York-based biotechnology company that develops medicines for eye diseases, dermatitis, asthma, and other ailments. One of the firm’s most important products is its treatment for age-related macular degeneration. The drug is called Eyelea, and it is key to Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)’s hypothesis as was evident in October last year when the shares dropped by 9% after a higher dose variant of the drug missed analyst sales estimates. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)’s shares are down by 3.4% year-to-date, and here’s what Cramer said about the stock:
“I’ll be doing Regeneron, which is another stock that seems to have disappointed people. Bizarre.”
7. Abbott Laboratories (NYSE:ABT)
Number of Hedge Fund Holders In Q3 2024: 63
Abbott Laboratories (NYSE:ABT) is one of the biggest healthcare and pharmaceutical companies in the world. The firm’s shares are flat year-to-date and they closed 2024 just 3.8% higher. While the broader pharmaceutical industry didn’t perform well last year due to interest rates and inflationary pressures, some of Abbott Laboratories (NYSE:ABT)’s struggles were specific to the firm. The firm was ordered to pay $495 million in damages related to its infant formula in July. The stock soared by 4.6% in November after a jury cleared it of liability. Here’s what Cramer said about Abbott Laboratories (NYSE:ABT):
“Abbott, not understood very well because they’re doing tremendous stuff when it comes to diabetes. People don’t seem to care.”
6. Merck & Co., Inc. (NYSE:MRK)
Number of Hedge Fund Holders In Q3 2024: 86
Merck & Co., Inc. (NYSE:MRK) is a global pharmaceutical giant that has led the specialty drug market through its KEYTRUDA cancer drug. KEYTRUDA is one of the most widely sold drugs in the world and is expected to cross $60 billion in sales by 2026. Building on the back of its strong cancer drug, Merck & Co., Inc. (NYSE:MRK) estimates that it can earn as much as $20 billion in revenue from new cancer and oncology medicines by the mid-2030s. The stock jumped by 2.3% in January after a Chinese firm announced that it would sell an Ireland-based vaccine facility to Merck & Co., Inc. (NYSE:MRK) following tough US laws. Cramer’s previous comments have appreciated the firm’s GARDASIL HPV drug, and here’s his latest take:
“Merck, which is down very badly. Even though they’ve got Keytruda and a drug that’s going to be very much life saving.”
5. Tesla, Inc. (NASDAQ:TSLA)
Number of Hedge Fund Holders In Q3 2024: 99
Tesla, Inc. (NASDAQ:TSLA) is the largest pure-play electric vehicle manufacturer in the world. While most of the firm’s revenue is still generated by electric vehicles, Cramer’s recent discussions have focused on CEO Elon Musk and Tesla, Inc. (NASDAQ:TSLA)’s technology initiatives such as assisted driving and artificial intelligence. Musk himself has stated multiple times that Tesla, Inc. (NASDAQ:TSLA)’s biggest product in the future will be the Optimus humanoid robot lineup. Cramer’s latest remarks for the firm commented on how the market is misguided when it comes to Tesla, Inc. (NASDAQ:TSLA)’s narrative and a recent price target hike by Morgan Stanley:
“Okay so when they reported the quarter it was bad. It was bad relative to expectations. But the whole dialogue switched and it just became a robotaxi. And then it became technology. And I think David, you correctly hit on over and over again, this is a neural network company. The giant Tennessee, uh, land grab of GPUs from NVIDIA coupled with the brains in the car has made it so we [inaudible] can’t think about this as a car company, we have to think about this as an accelerated computing, generative AI, vehicle. And anytime we don’t do that, the stock’s worth $200 without that.”
“[On TSLA using generative AI for assisted driving] Cheaper. Uh, and I think more likely to end up on the Federal Interstate Highway System which is another story that we might as well just put out there since nobody can refute it. Which is that President-elect Trump will allow Tesla to be on the Federal Interstate Highway System. Who’s gonna stop that, David? Who can stop that one?”
4. Eli Lilly and Company (NYSE:LLY)
Number of Hedge Fund Holders In Q3 2024: 106
Eli Lilly and Company (NYSE:LLY) is one of the hottest healthcare stocks on the market courtesy of its weight loss drugs. The show dedicated quite a bit of airtime to the firm as Cramer was covering the JPMorgan Healthcare Conference as it was being aired. He interviewed Eli Lilly and Company (NYSE:LLY)’s CEO David Ricks as part of the coverage, and commented on the stock before and after the interview. Here’s what Cramer said:
“Yeah, I think that you’re gonna see some numbers at [a] level of growth that that’s unheard of frankly for a new drug. Some numbers to be put out that I think are really what you would get at for ten years. Blockbuster, blockbuster, I mean $25 billion. Now initially people are going to sell the stock, they’re gonna sell the stock because somehow they believe that it’s gonna miss the fourth quarter. The fourth quarter was always etched in stone. It was going to not be as good as their numbers. So David, it’s very hard to have a surprise when we already knew what they were going to do and it was in line. I suggest that people listen to our interview with David Ricks and figure out what 2025’s going to be, because 2024, already in the history books, doesn’t matter to the stock.”
“[on guidance of 32% midpoint revenue growth for 2025] Yeah, 32% very good numbers, I think what we’re going to have to focus on David, we’re going to have to ask Mr. Ricks about inventory, how much was there to sell, the demand side is insane, I care about demand more than I care about what these numbers are indicating. Let them sell, I look at it almost as you would on a trading desk, let them sell it. Let the uninformed people sell it. And then look at the size of this market, realize that we’re in its infancy. And its infancy is already so much bigger than any drug I’ve ever seen. I think you have to be on the horse that is Eli Lilly.”
“I think the problem with Eli Lilly is, as David Ricks admitted, there’s been some mistakes. They have not done the launch as easily as people thought. I say as I said in the beginning, let em sell it. I mean in the end this is the, GLP-1s the greatest drug of all time. It will be used for multiple indications. People wanted David Ricks to come out here and say, you know what, next year’s going to be far bigger than expected. He doesn’t play that game. It has never been the way he does things. We sold some stock when it was in the eight hundred, nine hundred, for my charitable trust. All I can say is, now I’m restricted, I can’t buy it back right now. I wish I could, down eight percent. I think it goes down ten percent as we get rid of people who don’t understand the story. And then people come in who understand the story, and they’ll buy the stock.”
3. Apple Inc (NASDAQ:AAPL)
Number of Hedge Fund Holders In Q3 2024: 158
Apple Inc (NASDAQ:AAPL) is the most valuable consumer technology company in the world. The stock’s performance in today’s AI era has been mixed. Apple Inc (NASDAQ:AAPL)’s shares were laggards ahead of the WWDC conference last year, but since the event, they added 29.81% through the year. In 2025, the shares are down by 4.3% year-to-date as investors wonder whether Apple Inc (NASDAQ:AAPL) can push AI to consumers through its products and if the iPhone can sustain sales momentum. Cramer, for his part, shared his take on Mark Zuckerberg’s comments that Apple Inc (NASDAQ:AAPL)’s innovation has slowed:
“Well, I think when you say that there’s been no innovation since Steve, Steve Jobs died, I don’t know, I find that inflammatory. But you know what. . . .that was rough, I wanted to go to them and say could you please tell me, I wanted to call them on my Apple devices and use the 72 Apple devices I have [inaudible] and as well as the revenue stream, and talk about how we have now become integrated worldwide with Apple. But you know what let’s just stick with Android.”
2. NVIDIA Corporation (NASDAQ:NVDA)
Number of Hedge Fund Holders In Q3 2024: 193
NVIDIA Corporation (NASDAQ:NVDA) has nearly appeared regularly on Cramer’s morning show in 2025 due to several factors. Firstly, CEO Jensen Huang’s opening Keynote at the Consumer Electronics Conference (CES) in Las Vegas saw the TV host share his thoughts before and after the announcements. In his previous remarks, Cramer was bullish on NVIDIA Corporation (NASDAQ:NVDA)’s ability to usher in a new industrial revolution through its AI products and by targeting industries such as robotics. More recently, his attention has shifted to media reports suggesting that NVIDIA Corporation (NASDAQ:NVDA) is suffering from supply problems with its latest Blackwell AI GPUs and new US export control rules:
“And you know look, I think you can’t be sanguine. You keep seeing things, the last minute things, uh, from President Biden. About what’s going on. This place has been completely roiled by what’s going on this weekend when it came to sovereign nations being able to have GPUs, being able to have the key generative AI chips and accelerated computing chips. I spoke to Jensen Huang last night. I mean there is just the CEO of NVIDIA, there’s just this chaos about what this administration’s doing at the last minute. David I don’t know what the administration is doing at the last minute. It’s almost as if they’re just saying, you know what, we’re going to throw up anything, we’re going to do anything. I’m waiting for something really horrible [for] oil and gas at the last minute.”
“[On NVDA customers facing delays because of glitches in server racks] Okay, story comes out, when? The day when quiet period begins. That happened the previous quarter. The day when quiet begins. It was done by The Information. You know David, it could be the disinformation. It could be, remember Pravda? I find that this kind of attack on NVIDIA has become standard. And instead I go to Jensen Huang, maybe he knows more, because he’s called the CEO. And he says that absolutely it’s shipping 45 factories. They’re getting them out as fast as they can. If anyone’s complaining, give me a break, I think that it is, next to David Ricks’ launch, Eli Lilly, for GLP-1s, I think the launch of Blackwell is as successful. So I get tired of the attacks on NVIDIA, they bore me.”
“I come back to the idea that we have one stock that is the elephant in the room, which is NVIDIA. I believe that NVIDIA has been hurt by the Commerce Department’s rules. I think those rules, these are the ones that came out at midnight this weekend, were a little absurd. They picked [inaudible] we have 18 friends. 18 friends. I mean by the way EU has 29 countries. What happened to Mexico. What happened to Israel. What happened to Iceland. Which is the 100% um clean energy. They were absurd. They were completely out of touch. I think NVIDIA can bounce back.”
1. Meta Platforms, Inc (NASDAQ:META)
Number of Hedge Fund Holders In Q3 2024: 235
Meta Platforms, Inc (NASDAQ:META) is one of the biggest social media companies in the world. The technology-focused nature of its CEO Mark Zuckerberg proved to be a boon for the stock in 2024. Meta Platforms, Inc (NASDAQ:META)’s shares ended the year 69% higher as investors were optimistic about its ability to monetize AI by selling features to advertisers. The firm also enjoys a strong moat in the AI sector as it has developed a foundational AI model. In 2025, Meta Platforms, Inc (NASDAQ:META)’s been in the news for scrapping fact-checking in the US and for Zuckerberg’s appearance on the Joe Rogan Experience podcast. Here’s what Cramer said:
“I know Meta AI is supposed to be the most exciting. I find it to be little more prurient. When it comes to the metaverse I thought that Ralph Lauren was supposed to have a mall right next to, I don’t know, Macy’s. Hasn’t really turned out that way but at the same time the dialogue has switched mostly to Taekwondo and rifles. And David, you better start shooting pigs [referring to Zuckerberg’s hobby of hunting boars] if you want to be on board here.
“Let them lower the price [of the Vision Pro]. I did buy the Meta glasses for everybody for the holiday. I have the Ray-Bans. I was always partial to the Ray-Bans to begin with.
“I’m still reeling from that Joe Rogan interview because it was two libertarians talking about no need for government, I don’t know Carl, it was just different. Wide ranging is the word you picked, and I think that’s absolutely right.”
META is a stock Jim Cramer recently talked about. While we acknowledge the potential of META as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than META but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.
Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
